First-line treatment of indolent lymphoma: axing CHOP?
Lancet
.
2013 Apr 6;381(9873):1163-5.
doi: 10.1016/S0140-6736(12)61965-5.
Epub 2013 Feb 20.
Authors
Caron A Jacobson
1
,
Arnold S Freedman
Affiliation
1
Dana-Farber Cancer Institute, Boston, MA 02215, USA.
PMID:
23433738
DOI:
10.1016/S0140-6736(12)61965-5
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Lymphoma, Mantle-Cell / drug therapy*